PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 14 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $550,890 | -15.6% | 750,000 | 0.0% | 0.00% | -20.0% |
Q4 2022 | $652,410 | -1.7% | 750,000 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $664,000 | +2.8% | 750,000 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $646,000 | -2.7% | 750,000 | 0.0% | 0.01% | +25.0% |
Q1 2022 | $664,000 | -3.3% | 750,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $687,000 | +3.8% | 750,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $662,000 | -1.2% | 750,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $670,000 | -0.3% | 750,000 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $672,000 | +3.2% | 750,000 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $651,000 | +5.3% | 750,000 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $618,000 | +2.0% | 750,000 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $606,000 | +22.9% | 750,000 | 0.0% | 0.01% | +25.0% |
Q1 2020 | $493,000 | -8.0% | 750,000 | 0.0% | 0.00% | +33.3% |
Q4 2019 | $536,000 | -79.6% | 750,000 | -80.0% | 0.00% | -82.4% |
Q3 2019 | $2,629,000 | -18.8% | 3,750,000 | -21.1% | 0.02% | -19.0% |
Q2 2019 | $3,238,000 | – | 4,750,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PenderFund Capital Management Ltd. | 20,060,000 | $22,713,000 | 5.56% |
SILVERBACK ASSET MANAGEMENT LLC | 7,707,000 | $6,912,000 | 0.94% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,615,000 | $31,948,000 | 0.74% |
DeepCurrents Investment Group LLC | 12,521,000 | $11,079,000 | 0.34% |
AGF Investments LLC | 4,000,000 | $3,502,000 | 0.29% |
WATER ISLAND CAPITAL LLC | 2,250,000 | $2,014,000 | 0.10% |
L & S Advisors Inc | 935,000 | $829,000 | 0.10% |
Sculati Wealth Management, LLC | 200,000 | $177,000 | 0.09% |
PALISADE CAPITAL MANAGEMENT, LP | 3,192,000 | $2,816,000 | 0.06% |
Teton Advisors, Inc. | 400,000 | $354,000 | 0.06% |